US Patent 11634422 Inhibitors of activin receptor-like kinase
Patent 11634422 was granted and assigned to Blueprint Medicines on April, 2023 by the United States Patent and Trademark Office.
All edits
Edits on 14 Aug, 2023
Golden AI
Edits made to:
Infobox (+9 properties)
Infobox
Patent Inventor Names
Brett D. Williams0
Brian Lewis Hodous0
Douglas Wilson0
Jason D. Brubaker0
Joseph L. Kim0
Kevin J. Wilson0
Mark Cronin0
Natasja Brooijmans0
Paul E. Fleming0
Edits on 30 Apr, 2023
Golden AI
Edits made to:
Infobox (+23 properties)
Article (+173 characters)
US Patent 11634422 Inhibitors of activin receptor-like kinase
Article
Described herein are compounds that inhibit ALK2 and its mutants, pharmaceutical compositions including such compounds, and methods of using such compounds and compositions.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
116344220
Date of Patent
April 25, 2023
0Patent Application Number
168872620
Date Filed
May 29, 2020
0Patent Citations
Patent Primary Examiner
Find more entities like US Patent 11634422 Inhibitors of activin receptor-like kinase
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
